Sclerosing Rhabdomyosarcoma, from the CureRays guide library.

Sclerosing rhabdomyosarcoma is a rare subtype of muscle-forming soft-tissue sarcoma with a distinctive dense, scar-like background, treated with the rhabdomyosarcoma approach of chemotherapy plus local control by surgery and radiation.

What it is.

Sclerosing rhabdomyosarcoma is a rare subtype of rhabdomyosarcoma — a cancer whose cells try to become skeletal muscle but never mature. What makes this subtype distinctive under the microscope is a dense, hardened (sclerosing) background that surrounds the tumor cells, sometimes making it resemble bone or cartilage tumors and requiring expert pathology and molecular testing to diagnose. Many of these tumors carry a specific gene change in the MYOD1 gene, which is important because it tends to signal a more aggressive course. Sclerosing rhabdomyosarcoma can occur in both children and adults and often arises in the head and neck or the arms and legs. Like other rhabdomyosarcomas, it is treated with a combination of chemotherapy to attack cancer throughout the body and 'local control' — surgery, radiation, or both — to eliminate the tumor where it started.

How radiation treats it.

Radiation damages the DNA inside cancer cells so they can no longer divide. In rhabdomyosarcoma, radiation is a central part of 'local control' — eliminating the tumor where it started — and is used when surgery cannot remove the tumor completely without unacceptable loss of function, or to clear microscopic disease left behind after surgery. It is especially important for tumors in places that are hard to operate on, such as the head and neck. Intensity-modulated radiation shapes the dose around the tumor, and proton therapy — particularly in children — further spares developing tissues to reduce long-term side effects on growth and organ function. Radiation is painless during delivery, given over several weeks of daily sessions alongside chemotherapy, and external-beam treatment leaves no radioactivity in the body.

The ways we can treat it.

Intensity-modulated radiation (IMRT). Beams are shaped around the tumor to deliver a high dose while sparing nearby normal tissue, important in the head and neck or near joints and growth plates.

Proton therapy (especially in children). Protons reduce dose to surrounding developing tissues, which is valuable for children to lower long-term side effects on growth and organ function.

Image-guided radiation. Daily imaging confirms the tumor's position before each treatment so the dose is delivered accurately as swelling shrinks during therapy.

Questions we hear often.

Why is this subtype important to identify? Sclerosing rhabdomyosarcoma can look like bone or cartilage tumors under the microscope, so expert pathology and molecular testing are needed to diagnose it correctly. Identifying it — and checking for a MYOD1 mutation — matters because it signals a more aggressive course and guides more intensive treatment.

Will my child need both surgery and radiation? Treatment always includes chemotherapy, plus 'local control' of the original tumor by surgery, radiation, or both. The choice depends on whether surgery can remove the tumor without major loss of function. In delicate areas like the head and neck, radiation is often the main local-control method.

Is it treated the same in adults and children? The same principles apply — chemotherapy plus local control with surgery and radiation — but children are usually treated on established rhabdomyosarcoma protocols. Adults are treated with similar approaches, ideally at a sarcoma center, since rhabdomyosarcoma is less common in adults.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.